Recruiting Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors NCT05176483 Conditions Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more Locations Exelixis Clinical Site #67 — Phoenix, Arizona, United States Exelixis Clinical Site #1 — Tucson, Arizona, United States Exelixis Clinical Site #123 — Palo Alto, California, United States Exelixis Clinical Site #59 — Santa Barbara, California, United States View all 122 locations View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study NCT07620574 Conditions Adenocarcinoma, Cancer, Carcinoma, +39 more Locations Not specified View Trial Details
